艾滋病毒感染中持续性CMV肺炎:一个病例报告
Abbye W Frederick1, Ellen Kitchell2, Clare McCormick-Baw2
1Division of Infectious Diseases & Geographic Medicine, University of Texas Southwestern, Dallas, TX, USA. abbye.frederick@utsouthwestern.edu.
BMC infectious diseases
|November 29, 2023
概括
在艾滋病毒患者中,细胞巨乳病毒 (CMV) 肺炎是罕见的. 这一案例突显了未经控制的HIV中复发的CMV肺炎,强调了更新治疗指南的必要性.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 病毒学 病毒学
背景情况:
- 细胞巨乳病毒 (CMV) 感染是艾滋病毒发病期晚期的个体的重大机会性感染.
- 作为一种严重表现的CMV肺炎,需要谨慎管理,特别是在不受控制的人类免疫缺陷病毒 (HIV) 感染的情况下.
研究的目的:
- 报告艾滋病毒感染患者罕见病理证明的CMV肺炎病例.
- 讨论在持续性不受控制的HIV的环境中管理复发性CMV肺炎的挑战.
- 突出需要更新的治疗指南的需要在艾滋病毒患者中治疗CMV肺炎.
主要方法:
- 一个艾滋病毒感染患者出现呼吸道症状的病例报告.
- 病理确认的CMV肺炎.
- 临床过程分析,包括治疗反应和复发.
主要成果:
- 患者出现咳和发烧,诊断为CMV肺炎.
- 尽管初始治疗,但症状复发,与不受控制的HIV复制有关.
- 这种复发突显了这一群体的治疗复杂性.
结论:
- 病理证明的CMV肺炎可能发生在HIV患者中.
- 在未经控制的HIV病例中,CMV肺炎的复发是令人担忧的.
- 需要进一步讨论HIV中CMV肺炎的最佳治疗策略.
更多相关视频
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
21.1K
05:53Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
15.0K
相关概念视频
01:30Pneumonia I: Introduction
245
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
245
01:28Pneumonia IV: Management
333
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
333
01:29Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
01:30Pneumonia III: Complications and Assessment
239
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
239